Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen *
Pharmacy Only: Prescription
Company:AstraZeneca Pharmaceuticals (Ireland) DAC
Status:No Recent Update
Legal Category:Product subject to medical prescription which may not be renewed (A)
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download)
Bydureon 2 mg Pre Filled Pen User Manual
Instructions for use
Discontinued Strength Notice
Bydureon 2 mg Powder and Solvent for Prolonged-Release Suspension for Injection in Pre-Filled Pen has been discontinued. It is expected that stock will be depleted by September 2022.